§ 13F · FUND PROFILE
MPM BIOIMPACT LLC.
Institutional filer · behavioral pattern: Other. Summary pending.
AUM · — (13F)Positions · 41Turnover · — · Q1Filed · May 15, 2026
CONCENTRATION
—
Top 10 holdings
NEW BUYS
0
+$322M deployed
EXITS
0
No exits
SECTOR SHIFT
—
No prior quarter data
3YR HIT RATE
—
Top-5 overlap
§ 01 · TOP HOLDINGS
The book · Q1 2026
FILED MAY 15, 2026
| # | Ticker | Name | Shares | $ value | % port | Δ Q1 |
|---|---|---|---|---|---|---|
| 1 | DBVT | DBV Technologies S A | 5.21M | $109M | 8.4% | +423% |
| 2 | CGEM | Cullinan Therapeutics, Inc. | 7.65M | $109M | 8.4% | ±0% |
| 3 | AKTS | Aktis Oncology, Inc. | 4.84M | $87M | 6.7% | NEW |
| 4 | LQDA | Liquidia Corporation | 1.41M | $53M | 4.1% | ±0% |
| 5 | ALMS | Alumis Inc | 2.39M | $53M | 4.1% | −1% |
| 6 | EWTX | Edgewise Therapeutics Inc | 1.66M | $52M | 4.0% | ±0% |
| 7 | RVMD | Revolution Medicines, Inc. | 507K | $49M | 3.8% | ±0% |
| 8 | AGIO | Agios Pharmaceuticals Inc | 1.31M | $44M | 3.4% | ±0% |
| 9 | CORT | Corcept Therapeutics, Inc. | 986K | $40M | 3.1% | NEW |
| 10 | TRVI | Trevi Therapeutics Inc | 3.30M | $39M | 3.0% | ±0% |
§ 02 · SECTOR ALLOCATION
Where the money is
Sector data pending
§ 03 · THE MPM SIGNAL
AC read
MPM BIOIMPACT LLC is classified as a Other fund.
Read the full dossier →§ 04 · FILING HISTORY
Q-by-Q deltas
1 FILINGS
Q1 2026
Steady book
+0 buys · −0 exits · 0 changed
Q4 2025
Steady book
+0 buys · −0 exits · 0 changed
Q1 2025
Steady book
+0 buys · −0 exits · 0 changed